These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

7525 related items for PubMed ID: 2467736

  • 1. Chemotherapy of disseminated melanoma with bleomycin, vincristine, CCNU, and DTIC (BOLD regimen). The Prudente Foundation Melanoma Study Group.
    Cancer; 1989 May 01; 63(9):1676-80. PubMed ID: 2467736
    [Abstract] [Full Text] [Related]

  • 2. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma.
    Pyrhönen S, Hahka-Kemppinen M, Muhonen T, Nikkanen V, Eskelin S, Summanen P, Tarkkanen A, Kivelä T.
    Cancer; 2002 Dec 01; 95(11):2366-72. PubMed ID: 12436444
    [Abstract] [Full Text] [Related]

  • 3. Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF.
    Bottoni U, Bonaccorsi P, Devirgiliis V, Panasiti V, Borroni RG, Trasimeni G, Clerico R, Calvieri S.
    Jpn J Clin Oncol; 2005 Sep 01; 35(9):507-13. PubMed ID: 16120623
    [Abstract] [Full Text] [Related]

  • 4. Influence of therapy on the antioxidant status in patients with melanoma.
    Gadjeva V, Dimov A, Georgieva N.
    J Clin Pharm Ther; 2008 Apr 01; 33(2):179-85. PubMed ID: 18315784
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-2 plus chemotherapy for patients with metastatic melanoma.
    Paciucci PA, Ryder JS, Mandell JP, Morris JC, Holland JF.
    Melanoma Res; 2000 Jun 01; 10(3):291-5. PubMed ID: 10890384
    [Abstract] [Full Text] [Related]

  • 6. [Results of a randomized polychemotherapy study in malignant melanoma].
    Fiedler H, Hetschko I, Wohlrab W, Wozniak KD, Lübbe D, Taube KM.
    Hautarzt; 1990 Jul 01; 41(7):369-74. PubMed ID: 1698185
    [Abstract] [Full Text] [Related]

  • 7. A phase II study of neoadjuvant biochemotherapy for stage III melanoma.
    Gibbs P, Anderson C, Pearlman N, LaClaire S, Becker M, Gatlin K, O'Driscoll M, Stephens J, Gonzalez R.
    Cancer; 2002 Jan 15; 94(2):470-6. PubMed ID: 11900232
    [Abstract] [Full Text] [Related]

  • 8. Combination cytotoxic chemotherapy with procarbazine, vincristine, and lomustine (POC) in disseminated malignant melanoma: 8 years' follow-up.
    Carmo-Pereira J, Costa FO, Henriques E.
    Cancer Treat Rep; 1984 Oct 15; 68(10):1211-4. PubMed ID: 6525593
    [Abstract] [Full Text] [Related]

  • 9. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
    Musolino A, Perrone MA, Michiara M, Delnevo D, Franciosi V, Di Blasio B, Ceci G, Camisa R, Ardizzoni A, Cocconi G.
    Cancer; 2005 May 15; 103(10):2109-17. PubMed ID: 15803492
    [Abstract] [Full Text] [Related]

  • 10. DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).
    Carter RD, Krementz ET, Hill GJ, Metter GE, Fletcher WS, Golomb FM, Grage TB, Minton JP, Sparks FC.
    Cancer Treat Rep; 1976 May 15; 60(5):601-9. PubMed ID: 991149
    [Abstract] [Full Text] [Related]

  • 11. Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU.
    Einhorn LH, Furnas B.
    Cancer Treat Rep; 1977 Aug 15; 61(5):881-3. PubMed ID: 329981
    [Abstract] [Full Text] [Related]

  • 12. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
    Kretschmer L, Helmbold P, Emmert S, Marsch WC.
    Hautarzt; 2002 Aug 15; 53(8):536-41. PubMed ID: 12221468
    [Abstract] [Full Text] [Related]

  • 13. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
    Serrone L, Zeuli M, Sega FM, Cognetti F.
    J Exp Clin Cancer Res; 2000 Mar 15; 19(1):21-34. PubMed ID: 10840932
    [Abstract] [Full Text] [Related]

  • 14. Lomustine, vincristine, and procarbazine in the treatment of metastatic malignant melanoma.
    Shelley W, Quirt I, Bodurtha A, Iscoe N, Russell J, Paterson A, Young V.
    Cancer Treat Rep; 1985 Sep 15; 69(9):941-4. PubMed ID: 2992784
    [Abstract] [Full Text] [Related]

  • 15. [Chemotherapy of malignant melanoma].
    Ishihara K, Yamazaki N, Asano K.
    Gan To Kagaku Ryoho; 1993 Aug 15; 20(10):1287-92. PubMed ID: 7688498
    [Abstract] [Full Text] [Related]

  • 16. Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanoma.
    Nieboer P, Mulder NH, Van Der Graaf WT, Willemse PH, Hospers GA.
    Anticancer Res; 2001 Aug 15; 21(4B):3115-6. PubMed ID: 11712820
    [Abstract] [Full Text] [Related]

  • 17. Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG).
    Hauschild A, Garbe C, Stolz W, Ellwanger U, Seiter S, Dummer R, Ugurel S, Sebastian G, Nashan D, Linse R, Achtelik W, Mohr P, Kaufmann R, Fey M, Ulrich J, Tilgen W.
    Br J Cancer; 2001 Apr 20; 84(8):1036-42. PubMed ID: 11308250
    [Abstract] [Full Text] [Related]

  • 18. Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
    Daponte A, Ascierto PA, Gravina A, Melucci MT, Palmieri G, Comella P, Cellerino R, DeLena M, Marini G, Comella G, Italian Cooperative Oncology Group.
    Cancer; 2000 Dec 15; 89(12):2630-6. PubMed ID: 11135225
    [Abstract] [Full Text] [Related]

  • 19. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU, Mavligit GM, Reed R, Burgess MA, Gottlieb J, Hersh EM.
    Cancer Treat Rep; 1976 Feb 15; 60(2):177-82. PubMed ID: 769970
    [Abstract] [Full Text] [Related]

  • 20. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
    Wagenaar HC, Colombo N, Vergote I, Hoctin-Boes G, Zanetta G, Pecorelli S, Lacave AJ, van Hoesel Q, Cervantes A, Bolis G, Namer M, Lhommé C, Guastalla JP, Nooij MA, Poveda A, Scotto di Palumbo V, Vermorken JB.
    Gynecol Oncol; 2001 Jun 15; 81(3):348-54. PubMed ID: 11371121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 377.